rs16825455
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs16825455(A;A) |
| Make rs16825455(A;G) |
| Make rs16825455(G;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 1 |
| Position | 21511262 |
| Gene | ALPL |
| is a | snp |
| is | mentioned by |
| dbSNP | rs16825455 |
| dbSNP (classic) | rs16825455 |
| ClinGen | rs16825455 |
| ebi | rs16825455 |
| HLI | rs16825455 |
| Exac | rs16825455 |
| Gnomad | rs16825455 |
| Varsome | rs16825455 |
| LitVar | rs16825455 |
| Map | rs16825455 |
| PheGenI | rs16825455 |
| Biobank | rs16825455 |
| 1000 genomes | rs16825455 |
| hgdp | rs16825455 |
| ensembl | rs16825455 |
| geneview | rs16825455 |
| scholar | rs16825455 |
| rs16825455 | |
| pharmgkb | rs16825455 |
| gwascentral | rs16825455 |
| openSNP | rs16825455 |
| 23andMe | rs16825455 |
| SNPshot | rs16825455 |
| SNPdbe | rs16825455 |
| MSV3d | rs16825455 |
| GWAS Ctlg | rs16825455 |
| GMAF | 0.2245 |
| Max Magnitude | 0 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
| GWAS snp | |
|---|---|
| PMID | [PMID 23648065 ]
|
| Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs) |
| Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
| Risk Allele | T |
| P-val | 9E-6 |
| Odds Ratio | 1.43 [1.193-1.702] |
